1-溴-4-异丁氧基苯 | 30752-23-9

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 1-溴-4-异丁氧基苯
• 英文名称: 1-bromo-4-isobutoxybenzene
• 英文别名: 4-bromophenyl iso-butyl ether；1-bromo-4-(2-methylpropoxy)benzene
• CAS: 30752-23-9
• 化学式: C₁₀H₁₃BrO
• mdl: MFCD11127625
• 分子量: 229.117
• InChiKey: FMAIALVMJJUXSB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 危险性防范说明：
  P501,P270,P264,P280,P302+P352,P337+P313,P305+P351+P338,P362+P364,P332+P313,P301+P312+P330
• 危险性描述：
  H302,H315,H319

反应信息

• 作为反应物：
  描述：

  1-溴-4-异丁氧基苯 在 copper(l) iodide 、 potassium carbonate 、 L-脯氨酸 、 sodium t-butanolate 作用下， 以 二甲基亚砜 、 甲苯 为溶剂， 反应 92.08h， 生成 4-([2,2':6',2"-terpyridin]-4'-yl)-N,N-bis(4-isobutoxyphenyl)aniline
  参考文献：
  名称：

  Alkyl chain-functionalized hole-transporting domains in zinc(II) dye-sensitized solar cells

  摘要：

  FTO/TiO2 electrodes have been functionalized with {Zn(tpy(anchor))(tpy(ancillary))}(2+) dyes (tpy = 2,2':6',2 ''-terpyridine) using a stepwise method to sequentially introduce (i) the anchoring ligand tpy(anchor) (either a dicarboxylic acid or a diphosphonic acid), (ii) Zn2+ ions, and (iii) chromophoric ancillary (4-([2,2':6',2 ''-terpyridin]-4'-yl)-N,N-bis(4-alkoxyphenyl)aniline ligands. A comparison of unmasked and fully masked DSSCs containing representative dyes shows a significant drop in photon-to-current efficiency upon masking. Solid-state absorption spectra of the dye-functionalized electrodes confirm that the intensity of absorption decreases with the steric demands of the ancillary ligand. DSSC measurements show that the {Zn(tpy(anchor))(tpy(ancillary))}(2+) dyes give poor photon-to-current efficiencies, values of the short circuit current density (J(SC)) and the external quantum efficiency (EQE) spectra are consistent with very poor electron injection. Introducing longer alkoxy chains in place of methoxy substituents in the hole-transporting domains in tpyancillary is beneficial, resulting in increased J(SC) and V-OC, although values remain low despite the 'push-pull' design of the sensitizers. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.dyepig.2015.01.008
• 作为产物：
  描述：

  (isobutyloxy)benzene 在 aluminum oxide 、 sodium chlorite 、 水 、 manganese(III) acetylacetonate 、 sodium bromide 作用下， 以 二氯甲烷 为溶剂， 反应 1.67h， 以96%的产率得到1-溴-4-异丁氧基苯
  参考文献：
  名称：

  A SIMPLE REGIOSELECTIVE NUCLEAR BROMINATION OF ALKYL PHENYL ETHERS

  摘要：

  DOI：

  10.1080/00304949809355283

文献信息

• [EN] ARYLSULFONAMIDE-BASED MATRIX METALLOPROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE MÉTALLOPROTÉASES MATRICIELLES À BASE D'ARYLSULFONAMIDES
  申请人：NOVARTIS AG

  公开号：WO2009118292A1

  公开（公告）日：2009-10-01

  The present invention provides a compound of formula (I):said compound is inhibitor of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP-13, and thus can be employed for the treatment of a disorder or disease characterized by abnormal activity of MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12 and/or MMP- 13. Accordingly, the compound of formula (I) can be used in treatment of disorders or diseases mediated by MMP-2, and/or MMP-8, and/or MMP-9, and/or MMP-12, and/or MMP- 13. Finally, the present invention also provides a pharmaceutical composition.

  本发明提供了一种化合物，其化学式为(I)：所述化合物是MMP-2、和/或MMP-8、和/或MMP-9、和/或MMP-12和/或MMP-13的抑制剂，因此可用于治疗由MMP-2、和/或MMP-8、和/或MMP-9、和/或MMP-12和/或MMP-13异常活性特征的疾病或疾病。因此，化合物(I)的化合物可用于治疗由MMP-2、和/或MMP-8、和/或MMP-9、和/或MMP-12、和/或MMP-13介导的疾病或疾病。最后，本发明还提供了一种药物组合物。
• Facile One-Pot Transformation of Arenes into Aromatic Nitriles under Metal-Cyanide-Free Conditions
  作者：Toshiyuki Tamura、Katsuhiko Moriyama、Hideo Togo

  DOI：10.1002/ejoc.201403672

  日期：2015.3

  Electron-rich arenes bearing methyl or methoxy groups on the aromatic ring were treated with dichloromethyl methyl ether and ZnBr2, and then with molecular iodine and aq. ammonia to give the corresponding aromatic nitriles in good yields. Using this method, febuxostat was efficiently prepared from 4-bromophenol in four steps. The method can be used for the preparation of aromatic nitriles from arenes

  芳环上带有甲基或甲氧基的富电子芳烃用二氯甲基甲基醚和 ZnBr2 处理，然后用分子碘和水溶液处理。氨以良好的收率得到相应的芳香腈。使用这种方法，可以通过四步从 4-溴苯酚有效地制备非布司他。该方法可用于在无金属氰化物条件下由芳烃一锅法制备芳香腈。
• [EN] SYNTHETIC INTERMEDIATE OF OXAZOLE COMPOUND AND METHOD FOR PRODUCING THE SAME<br/>[FR] INTERMÉDIAIRE SYNTHÉTIQUE D'UN COMPOSÉ OXAZOLE ET PROCÉDÉ DE PRODUCTION ASSOCIÉ
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2011093529A1

  公开（公告）日：2011-08-04

  An object of the present invention is to provide a method for producing an oxazole compound in a high yield. The object can be achieved by a compound represented by Formula (11): wherein R1 is a hydrogen atom or lower-alkyl group; R2 is a 1-piperidyl group substituted at the 4-position with a substituent selected from (A1a) a phenoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1b) a phenoxy-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkyl groups, (A1c) a phenyl-substituted lower-alkoxy lower-alkyl group substituted on the phenyl moiety with halogen, (A1d) a phenyl-substituted lower-alkyl group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups, (A1e) an amino group substituted with a phenyl group substituted with one or more halogen-substituted lower-alkoxy groups, and a lower-alkyl group, and (A1f) a phenyl-substituted lower-alkoxy group substituted on the phenyl moiety with one or more halogen-substituted lower-alkoxy groups; n is an integer from 1 to 6; and X3 is an organic sulfonyloxy group.

  本发明的目的是提供一种高产率生产噁唑化合物的方法。该目的可以通过由式（11）表示的化合物实现：其中R1是氢原子或较低的烷基基团；R2是在4-位被取代的1-哌啶基团，所述取代基选自（A1a）苯氧基在苯基上取代一个或多个卤素取代的较低烷氧基团，（A1b）苯氧基取代的较低烷基基团在苯基上取代一个或多个卤素取代的较低烷基基团，（A1c）苯基取代的较低烷氧基较低烷基基团在苯基上取代卤素，（A1d）苯基取代的较低烷基基团在苯基上取代一个或多个卤素取代的较低烷氧基团，（A1e）氨基取代的苯基取代一个或多个卤素取代的较低烷氧基团和较低烷基基团，以及（A1f）苯基取代的较低烷氧基团在苯基上取代一个或多个卤素取代的较低烷氧基团；n是1到6之间的整数；X3是有机磺酰氧基团。
• Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na_V1.7 Inhibitors for the Treatment of Pain
  作者：Guanglin Luo、Ling Chen、Amy Easton、Amy Newton、Clotilde Bourin、Eric Shields、Kathy Mosure、Matthew G. Soars、Ronald J. Knox、Michele Matchett、Rick L. Pieschl、Debra J. Post-Munson、Shuya Wang、James Herrington、John Graef、Kimberly Newberry、Digavalli V. Sivarao、Arun Senapati、Linda J. Bristow、Nicholas A. Meanwell、Lorin A. Thompson、Carolyn Dzierba

  DOI：10.1021/acs.jmedchem.8b01550

  日期：2019.1.24

  3-aryl-indazole derivatives were identified as potent and selective Nav1.7 inhibitors. Compound 29 was shown to be efficacious in the mouse formalin assay and also reduced complete Freund’s adjuvant (CFA)-induced thermal hyperalgesia and chronic constriction injury (CCI) induced cold allodynia and models of inflammatory and neuropathic pain, respectively, following intraperitoneal (IP) doses of 30 mg/kg

  3-芳基吲哚和3-芳基吲唑衍生物被确定为有效的和选择性的Na v 1.7抑制剂。化合物29在小鼠福尔马林测定中显示有效，并且在腹膜内（IP）后分别降低了完全弗氏佐剂（CFA）引起的热痛觉过敏和慢性收缩损伤（CCI）引起的冷痛觉过敏以及炎性和神经性疼痛模型剂量为30 mg / kg。观察到的功效可能与小鼠背根神经节暴露和Na V 1.7效价与29相关。
• [EN] 5-[(1S)-1-(4-BROMOPHENOXY)ETHYL]-2H-TETRAZOLE DERIVATIVES AND RELATED COMPOUNDS AS CLC-1 ION CHANNEL INHIBITORS FOR TREATING NEUROMUSCULAR DISORDERS<br/>[FR] DÉRIVÉS DE 5-[(1S)-1-(4-BROMOPHÉNOXY)ÉTHYL]-2 H-TÉTRAZOLE ET COMPOSÉS APPARENTÉS EN TANT QU'INHIBITEURS DE CANAL IONIQUE CLC-1 POUR LE TRAITEMENT DE TROUBLES NEUROMUSCULAIRES
  申请人：NMD PHARMA AS

  公开号：WO2020254558A1

  公开（公告）日：2020-12-24

  The present disclosure relates to compounds suitable for treating, ameliorating and/or preventing neuromuscular disorders, including the reversal of drug-induced neuromuscular blockade. The compounds as defined herein can inhibit the ClC-1 ion channel.

  本公开涉及适用于治疗、改善和/或预防神经肌肉疾病的化合物，包括逆转药物诱导的神经肌肉阻滞。本文定义的化合物可以抑制ClC-1离子通道。